Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 130.55
+0.65 (0.50%)
At close: Apr 16, 2026
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 4.56 billion as of April 16, 2026. Its market cap has decreased by -20.19% in one year.
Market Cap
4.56B
Enterprise Value
4.52B
Revenue
2.07B
Ranking
n/a
PE Ratio
16.38
Stock Price
130.55
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 4.56B, an increase of 31,745.52%. That is a compound annual growth rate of 26.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 4.54B | -19.51% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kopran | 7.51B |
| Sudarshan Pharma Industries | 7.39B |
| Jenburkt Pharmaceuticals | 4.55B |
| Albert David | 4.09B |
| Amanta Healthcare | 3.89B |
| ZIM Laboratories | 3.89B |
| Medico Remedies | 3.23B |
| Medicamen Biotech | 3.08B |